IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

PURPOSE: To report toxicity and early survival data for IDEAL-CRT, a trial of dose-escalated concurrent chemoradiotherapy (CRT) for non-small cell lung cancer. PATIENTS AND METHODS: Patients received tumor doses of 63 to 73 Gy in 30 once-daily fractions over 6 weeks with 2 concurrent cycles of cispl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Radiat Oncol Biol Phys
Asıl Yazarlar: Landau, David B., Hughes, Laura, Baker, Angela, Bates, Andrew T., Bayne, Michael C., Counsell, Nicholas, Garcia-Alonso, Angel, Harden, Susan V., Hicks, Jonathan D., Hughes, Simon R., Illsley, Marianne C., Khan, Iftekhar, Laurence, Virginia, Malik, Zafar, Mayles, Helen, Mayles, William Philip M., Miles, Elizabeth, Mohammed, Nazia, Ngai, Yenting, Parsons, Emma, Spicer, James, Wells, Paula, Wilkinson, Dean, Fenwick, John D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier Science Inc 2016
Konular:
Clinical Investigation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4959796/
https://ncbi.nlm.nih.gov/pubmed/27296040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2016.03.031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller